'I am truly thankful to be alive': 29-year-old Billy Price announces NFL retirement after undergoing clot-related surgery



Billy Price has announced that he is ending his NFL career due to health concerns.

The 29-year-old athlete noted in a social media post that he underwent emergency surgery in April.

'I am truly thankful to be alive today.'

"In the blink of an eye, everything can be taken away," Price noted. "On April 24th I had emergency pulmonary embolism surgery to remove a saddle clot that was entering both of my lungs. As a healthy 29 year old, an unprovoked pulmonary embolism with no further medical explanation is terrifying."

"I am truly thankful to be alive today. Unfortunately, I will be retiring from the NFL as the risk of an internal bleed while on blood thinners creates tremendous risk," he noted.

Price had previously played with the Cincinnati Bengals, New York Giants, and Arizona Cardinals, according to NFL.com. He had more recently worked on the Dallas Cowboys practice squad.

"I am truly thankful for the opportunity to have played in some of the greatest atmospheres around the world. I am thankful to have trained and played alongside men who will continue to make Pro Bowls, All Pro Rosters and Hall of Fame recognitions," Price noted. "To my wife: this career would not have been possible without your continued love and support. The sacrifices you have made over the course of my career do not go unnoticed. I cannot wait to navigate the next chapter in life with you as we continue to grow our family."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

AstraZeneca is withdrawing its vaccine globally after admitting it can cause potentially deadly blood clots



British-Swedish pharmaceutical giant AstraZeneca is taking its COVID-19 vaccine off the market worldwide.

While the move follows hard on the heels of the company's admission that its shot can cause potentially deadly blood clots and in the face of a class-action lawsuit brought by apparent victims and deceased victims' families, AstraZeneca has attributed the withdrawal to commercial considerations.

Background

The Oxford-AstraZeneca COVID-19 vaccine was a viral-vector vaccine developed in collaboration with Oxford University and produced for various companies by the Serum Institute of India. It relied upon a modified version of a chimpanzee adenovirus and was sold under various brand names, including Vaxzevria and Covishield.

Blaze News previously reported that the shot was approved for use in the U.K. in December 2020 and later approved by the World Health Organization. While never approved for rollout in the U.S., the Biden administration agreed to share up to 60 million doses with other nations.

Within a year of approval, the vaccine had been injected over 2.5 billion times worldwide.

The vaccine was not only touted by then-British Prime Minister Boris Johnson as a "triumph for British science" but passed off as "safe and effective" by the mainstream media and various so-called experts on both sides of the Atlantic.

Some unfortunate members of the British public and others around the world similarly cajoled into getting the vaccine were soon left with a firsthand understanding that the so-called experts were dead wrong.

Doctors started noticing in 2021 that otherwise healthy people were ending up with grievous injuries or even dying after receiving the AstaZeneca shot. Facing mounting evidence of a link between the vaccine and adverse side effects, various countries temporarily took the shot off the market, citing reports of abnormal bleeding, low blood platelets, blood clots, and sudden deaths.

German and Nordic researchers determined that some vaccine recipients were developing a clotting disorder called "vaccine-induced immune thrombotic thrombocytopenia," which generated antibodies that activated platelets and led to clots. Researchers indicated that the odds of the vaccine harming recipients was one in 100,000 — a higher likelihood than the vaccine actually keeping patients under 30 out of the hospital with COVID.

The Telegraph reported that among the hundreds of suspected thrombo-embolic events documented among British AstraZeneca patients, at least seven were ultimately fatal for victims in the 18-29 age cohort; 10 were fatal for victims ages 30-39; 17 were fatal for victims ages 40-49; 21 were fatal for victims ages 50-59; 11 were fatal for victims ages 60-69; seven were fatal for victims ages 70-79; and four were fatal for those 80 and over.

Legal action and admission

Jamie Scott, a father of two who was left with a permanent clot-related brain injury following his AstraZeneca vaccination in April 2021, sued the company last year. His effort to hold the pharmaceutical giant accountable set off an avalanche of similar complaints.

In the months since, over 50 other alleged vaccine victims have joined a class-action lawsuit against the company.

The Telegraph reported that the company told Scott's lawyers last year it did "not accept that [thrombosis with thrombocytopenia syndrome] is caused by the vaccine at a generic level."

However, AstraZeneca admitted in a February court document that "it is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known."

According to the Council for International Organizations of Medical Sciences, "very rare" side effects are those that occur in less than one in 10,000 cases, reported the Independent.

This admission was a big deal granted the company had repeatedly denied causation over the years.

For instance, in a March 14, 2021, statement, AstraZeneca claimed that a careful review showed "no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country."

Withdrawal

According to the Telegraph, AstraZeneca voluntarily withdrew its "marketing authorization" in the European Union on March 5, just weeks after filing court documents containing its blood-clot admission. This withdrawal application went into effect on Tuesday.

"This decision to withdraw marketing authorization, ending the usage of the AstraZeneca vaccine in the EU, will be welcomed," said a lawyer for the alleged victims of the vaccine, now engaged in a class-action lawsuit against the company.

The company, which did over $12 billion in product sales in Q1 2024, is expected to follow suit in other markets around the globe where its vaccine was approved.

The reason provided for the withdrawal is that the vaccine has been made redundant by other "updated vaccines."

AstraZeneca reportedly said in a statement, "We are incredibly proud of the role Vaxzevria played in ending the global pandemic. According to independent estimates, over 6.5 million lives were saved in the first year of use alone and over three billion doses were supplied globally."

"Our efforts have been recognized by governments around the world and are widely regarded as being a critical component of ending the global pandemic," continued the statement. "As multiple, variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied. AstraZeneca has therefore taken the decision to initiate withdrawal of the marketing authorizations for Vaxzevria within Europe."

"We will now work with regulators and our partners to align on a clear path forward to conclude this chapter and significant contribution to the Covid-19 pandemic," added the company.

Sarah Moore, a partner with the law firm representing the group action, told the Telegraph, "To those who we represent, all of whom have suffered bereavement or serious injury as a result of the AstraZeneca vaccine, this decision to withdraw marketing authorization, ending the usage of the AstraZeneca vaccine in the EU, will be welcomed."

Moore suggested further that the withdrawal will be viewed as a "decision linked with AstraZeneca's recent admission that the vaccine can cause TTS, and the fact that regulators across the world suspended or stopped usage of the vaccine following concerns regarding TTS."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

AstraZeneca vindicates skeptics with admission that its COVID-19 vaccine can cause blood clots



The British-Swedish pharmaceutical giant AstraZeneca has finally admitted that its COVID-19 vaccine can cause bloodclots.

While there were plenty of indications and fatalities over the years to suggest as much, the company and so-called experts around the world long downplayed the causal link along with critics' concerns.

Clot shot

The Oxford-AstraZeneca COVID-19 vaccine was a viral vector vaccine developed in the United Kingdom, which used a transmogrified version of a chimpanzee adenovirus. The shot wasapproved for use in the U.K. in December 2020 and later approved by the World Health Organization. It was not rolled out at the outset in the U.S., although the Biden administration did agree to share up to 60 million doses with other nations.

By January 2022, the vaccine had been injected globally more than 2.5 billion times.

More than 20 countries temporarily took AstraZeneca-Oxford vaccine off the market in March 2021 following mounting reports of abnormal bleeding, low blood platelets, blood clots, and sudden deaths among various recipients.

Some agencies had been caught off guard as blood clotting was not an advertised side effect of the vaccine. Reuters indicated that Australia's Federal Office for Safety in Health Care, for instance, was surprised when a 49-year-old nurse died from "severe coagulation disorders" after receiving the AstraZeneca vaccine.

USA Today indicated that some of the cases that raised red flags in 2021 involved blood clots in the lungs, the legs, throughout the blood, and in the brain.

German and Nordic researchers concluded that some vaccine recipients were developing a clotting disorder that produced antibodies that activated platelets and led to clots, reported the New York Times. What was then dubbed "vaccine-induced immune thrombotic thrombocytopenia" was believed to harm one in 100,000 recipients.

As a point of contrast, for patients under 30, the vaccine would prevent only 0.8 in 100,000 from going to the hospital with COVID, according to the Telegraph.

AstraZeneca repeatedly denied causation, noting in a March 14, 2021, statement that a careful review showed "no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country."

AstraZeneca added that the "available evidence does not confirm that the vaccine is the cause [of the clots]."

Despite an alarming number of apparent victims, various health organizations, including the European Medicines Agency, suggested that "the vaccine's benefits continue to outweigh its risks."

Multiple European countries resumed AstraZeneca vaccinations in late March after the European Medicine Agency claimed it was "safe and effective."

The World Health Organization doubled down in June 2022, claiming AstraZeneca was "safe and effective for individuals aged 18 and above," reported the BBC.

The cry of the so-called experts

The temporary caution exercised by some European nations was criticized by American medical professionals such as Paul Offit, director of the Vaccine Education Center and an infectious disease specialist at the Children's Hospital of Philadelphia, USA Today reported at the time.

"While it's easy to scare people, it's very hard to unscare them," said Offit. "It creates the perception that these vaccines are dangerous."

Offit further suggested that the "only way out of this pandemic is by vaccination, and if we make people reluctant to be vaccinated, we're going to have a hard time getting out of this pandemic."

"Unless there is an unusually high rate of blood clots among people receiving a particular vaccine, I just think it's quite dangerous to draw these kind of conclusions of causality without knowing," Akiko Iwasaki, an epidemiologist at Yale University, said in March 2021.

Daniel Salmon of Johns Hopkins' Institute for Vaccine Safety told the New York Times that vaccines had not been shown to cause blood clots.

Peter Hotez, a cable news vaccine promoter and the founding dean of the National School of Tropical Medicine at Baylor College of Medicine, claimed, "By unnecessarily suspending the AstraZeneca-Oxford vaccine, the European countries may have created a new problem."

Hotez suggested that the "vaccine ecosystem is fragile, and it doesn't take a lot to get a vaccine voted off the island."

Legal action

Jamie Scott, a father of two, was left with a permanent brain injury after developing a blood clot and bleed on his brain following his AstraZeneca vaccination in April 2021. On three occasions, his wife was told by hospital staff that Scott was going to die. Having so far survived his injury, Scott — certain the vaccine was "defective" — is now seeking to hold AstraZeneca accountable, reported the Telegraph.

Scott sued the company last year. At least 51 other alleged vaccine victims have since followed his lead, launching a group action under section 2 of the British Consumer Protection Act of 1987. Among the plaintiffs are the widower and two young children of Alpa Tailor, a 35-year-old who died after receiving the shot.

A coroner determined in September 2021 that the mother of two had died from blood clots on her brain. She began suffering stroke-like symptoms a week after her first dose of the AstraZeneca vaccine, reported the Daily Mail.

In the event that AstraZeneca loses in court, it could be forking over around $100 million in compensation. The British government will, however, underwrite the company's legal bills.

The admission

AstraZeneca told Scott's lawyers in March 2023, "We do not accept that [thrombosis with thrombocytopenia syndrome] is caused by the vaccine at a generic level."

However, the Telegraph noted that in a legal document submitted in February to the High Court of Justice in the U.K., the company noted, "It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known."

After confirming victims' suspicions, the company attempted to cast doubt on whether the plaintiffs were themselves victims of such "very rare cases," writing, "TTS can also occur in the absence of the AZ vaccine (or any vaccine). Causation in any individual case will be a matter for expert evidence."

According to the Council for International Organizations of Medical Sciences, "very rare" side effects are those that occur in less than one in 10,000 cases, reported the Independent.

The company has reportedly also attempted to cover itself, claiming that the product information concerning the AstraZeneca vaccine was updated in April 2021 to note "the possibility that the AstraZeneca-Oxford vaccine is capable, in very rare cases, of being a trigger" for TTS.

Kate Scott, the first plaintiff's wife, told the Telegraph, "The medical world has acknowledged for a long time that VITT was caused by the vaccine. It's only AstraZeneca who have questioned whether Jamie’s condition was caused by the jab."

"It's taken three years for this admission to come. It's progress, but we would like to see more from them and the Government. It's time for things to move more quickly," said the victim's wife. "We need an apology, fair compensation for our family and other families who have been affected. We have the truth on our side, and we are not going to give up."

Sarah Moore, a partner with the law firm representing the group action, said in a statement, "It has taken AstraZeneca a year to formally admit that their vaccine has caused this harm, when this was a fact widely accepted by the clinical community since the end of 2021: In that context, regrettably it seems that AstraZeneca, the Government and their lawyers are more keen to play strategic games and run up legal feels than to engage seriously with the devastating impact that the vaccine has had upon our clients' lives."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!